Document Detail

Implications of pre-procedural TIMI flow in patients with non ST-segment elevation acute coronary syndromes undergoing percutaneous coronary revascularization: Insights from the ACUITY trial.
MedLine Citation:
PMID:  22464479     Owner:  NLM     Status:  Publisher    
OBJECTIVES: The purpose of this study was to evaluate the prognostic implications of preprocedural TIMI flow in ACS patients undergoing early invasive management. BACKGROUND: Although the negative prognostic impact of reduced Thrombolysis in Myocardial Infarction (TIMI) flow before percutaneous coronary intervention (PCI) in ST-segment elevation myocardial infarction (STEMI) has been well described, whether this relationship holds in patients with acute coronary syndromes (ACS; unstable angina and non-STEMI) has not been examined. METHODS: We evaluated 3582 moderate and high-risk patients with ACS undergoing PCI enrolled in the ACUITY trial. Patients were divided in 3 groups according to pre-procedural culprit vessel TIMI flow (TIMI 0/1, TIMI 2 and TIMI 3 flows), determined by an independent angiographic core laboratory. RESULTS: Baseline culprit vessel flow was absent (TIMI 0/1) in 453 patients (12.6%), reduced (TIMI 2) in 389 patients (10.9%) and normal (TIMI 3) in 2740 patients (76.5%) patients. Post-PCI TIMI 3 flow was achieved in 87.2%, 86.8% and 98.8% of the 3 groups, respectively (P<0.0001). At 1year, mortality occurred in 2.7%, 2.4% and 3.0% of patients with baseline TIMI 0/1, 2 and 3 flows, respectively (P=0.82). By multivariable analysis, pre-PCI TIMI flow 0/1 (vs. TIMI 3) was not an independent predictor of 1-year mortality (P=0.61). CONCLUSIONS: Reduced baseline TIMI flow in moderate and high-risk patients with ACS undergoing PCI does not appear to affect survival at 1year, in contrast to that described in patients with STEMI.
Giuseppe De Luca; Sorin J Brener; Roxana Mehran; Alexandra J Lansky; Brent T McLaurin; David A Cox; Ecaterina Cristea; Martin Fahy; Gregg W Stone
Related Documents :
22050029 - Impact of electrocardiographic interpretability on outcome in patients referred for str...
22869839 - Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, i...
2568179 - Early intravenous beta-blockade in acute myocardial infarction.
16079169 - Excess recurrent cardiac events in rheumatoid arthritis patients with acute coronary sy...
8261479 - Aortic dissection due to discontinuation of beta-blocker therapy.
7897129 - Time course of improvement in left ventricular function, mass and geometry in patients ...
1591839 - Preconditioning does not attenuate myocardial stunning.
2252709 - Maintenance of circulation during ventricular fibrillation with the simultaneous use of...
9725159 - Effects of left atrial dilatation on the endocardial atrial defibrillation threshold: a...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-3-29
Journal Detail:
Title:  International journal of cardiology     Volume:  -     ISSN:  1874-1754     ISO Abbreviation:  -     Publication Date:  2012 Mar 
Date Detail:
Created Date:  2012-4-2     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8200291     Medline TA:  Int J Cardiol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.
Division of Cardiology, Eastern Piedmont University, Novara, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  No consistent evidence of differential cardiovascular risk amongst proton-pump inhibitors when used ...
Next Document:  Protective effects of valsartan against cigarette smoke-induced left ventricular systolic dysfunctio...